Journal of Stroke

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial

Eun-Jae Lee, Sun U. Kwon, Jong-Ho Park, Yong-Jae Kim, Keun-Sik Hong, Sungwook Yu, Yang-Ha Hwang, Ji Sung Lee, Juneyoung Lee, Joung-Ho Rha, Sung Hyuk Heo, Sung Hwan Ahn, Woo-Keun Seo, Jong-Moo Park, Ju-Hun Lee, Jee-Hyun Kwon, Sung-Il Sohn, Jin-Man Jung, Hahn Young Kim, Eung-Gyu Kim, Sung Hun Kim, Jae-Kwan Cha, Man-Seok Park, Hyo Suk Nam, Dong-Wha Kang,

J Stroke. 2020;22(1):108-118. Published online January 31, 2020
DOI: https://doi.org/10.5853/jos.2019.02551

Association of High-Density Lipoprotein Cholesterol With Incident Cardiovascular Events in Women, by Low-Density Lipoprotein Cholesterol and Apolipoprotein B100 Levels: A Cohort Study

P.P. Toth

Yearbook of Endocrinology. 2012;2012:35-41

Link1 Link2

High-Density Lipoprotein and High-Density Lipoprotein Cholesterol

Kayla A. Riggs, Anand Rohatgi

Biomarkers in Cardiovascular Disease. 2019;61-69

Link1 Link2

HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL IS ASSOCIATED WITH RESIDUAL RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DESPITE OPTIMAL LEVELS OF LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL: A POST HOC ANALYSIS FROM THE COURAGE TRIAL

Subroto Acharjee, William E. Boden, Pamela M. Hartigan, Koon K. Teo, David J. Maron, Steven P. Sedlis, Bernard R. Chaitman, John A. Spertus, Marcin Dada, G.B. John Mancini, Robert A. O'Rourke, William S. Weintraub

Journal of the American College of Cardiology. 2011;57(14):E1046

Link1 Link2

The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH) trial

American Heart Journal. 2011;161(3):538-543

Link1 Link2

Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial

Sander J Robins

The American Journal of Cardiology. 2001;88(12):19-23

Link1 Link2

American Heart Journal. 2011;161(3):471-477.e2

Link1 Link2

Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial

Journal of Stroke. 2020;22(1):108-118

Link1

Link2 Link3

Addressing cardiovascular risk beyond low-density lipoprotein cholesterol: the high-density lipoprotein cholesterol story

Emma A. Meagher

Current Cardiology Reports. 2004;6(6):457-463

Link1

Link2 Link3

High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from framingham to the veterans affairs high-density lipoprotein intervention trial

William E Boden

The American Journal of Cardiology. 2000;86(12):19-22

Link1 Link2

Association between size of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol particles and cardiovascular events in type 2 diabetes subjects

G. Lo Coco, J. Sanz Molina, F. Luciani, C.M. Semprini, E. Dalla Nora, G. Zuliani, G.B. Vigna, A. Passaro

Atherosclerosis. 2020;315:e201

Link1 Link2